Researchers are looking into whether GLP-1 drugs could have an effect on biological aging. The share gives few details, so tap through for what the work actually shows.
Recap by typeshit. Post by Facebook on Facebook.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
DrAlo points to a 20% drop in heart attacks and strokes among patients on a weight loss drug, people who did not have diabetes.
Loading…